Article: Afatinib prolongs survival of non-small cell lung cancer patients with an exon 19 deletion and delays progression in patients with squamous cell carcinoma of the lung

3.03

SKU: product-article-11262 Category:

Description

Afatinib prolongs survival of non-small cell lung cancer patients with an exon 19 deletion and delays progression in patients with squamous cell carcinoma of the lung

Reviews

There are no reviews yet.

Be the first to review “Article: Afatinib prolongs survival of non-small cell lung cancer patients with an exon 19 deletion and delays progression in patients with squamous cell carcinoma of the lung”